CoreCap Advisors’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
SCM
RCMC
BCM
RIM
CoreCap Advisors's IRMD Position: Q3 2022 in Review
CoreCap Advisors sold out of iRadimed (IRMD) in Q3 2022, closing a stake of 60 shares — an estimated $2K sold.
CoreCap Advisors first reported a position in IRMD in Q4 2021 and held it in 2 quarters. The position peaked at $3K in Q4 2021. 86 funds tracked by Wall St. Rank hold IRMD as of Q3 2022.
- CoreCap Advisors reported no remaining iRadimed position as of Q3 2022 after selling out during the quarter.
- CoreCap Advisors sold 60 iRadimed shares in Q3 2022, an estimated $2K.
- CoreCap Advisors first reported a position in iRadimed in Q4 2021 and held it in 2 quarters.
- CoreCap Advisors's iRadimed position peaked at $3K in Q4 2021.
- 86 funds tracked by Wall St. Rank held iRadimed as of Q3 2022.
Based on CoreCap Advisors's 13F filing for Q3 2022, filed 10 Feb 2023.